Amaryl Tablet

Amaryl 1 mg Tablet সম্পর্কে

Amaryl 1 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Glimepiride এবং শক্তি ১ mg। Amaryl-এর প্রতি ইউনিটের দাম ৬.৯২ টাকা। Amaryl-এর সাথে Glimepiride-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। Amaryl প্রস্তুত করেছে Synovia Pharma PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Glimepiride-এর ৪১টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১৫টি। সবচেয়ে কম দাম Mepid 1 mg Tablet-এর, প্রতি ইউনিট ৳ ২.৫১।

Amaryl 1 mg Tablet কী?

Made by Synovia Pharma PLC., Amaryl is a tablet whose active ingredient is Glimepiride. It helps lower blood glucose in adults with type II (non-insulin dependent) diabetes whose blood sugar is not controlled by diet and exercise alone. The dose and course are set by your doctor based on your blood sugar levels.

Amaryl-এর ব্যবহার

It is not suitable for type I diabetes, diabetic ketoacidosis or diabetic coma. Amaryl 1 mg tablet is used to lower blood glucose in adults with type II (non-insulin dependent) diabetes mellitus when diet and exercise alone are not enough. It may also be prescribed alongside metformin when diet, exercise and either medicine alone do not give adequate control. Your doctor will confirm whether this medicine is appropriate for your condition.

Amaryl কীভাবে ব্যবহার করবেন

Follow your diet and exercise plan as advised. Amaryl is taken by mouth. Swallow the tablet with water. If a dose is missed, ask the doctor or pharmacist for advice. The doctor decides the dose, how often to take it, and how long the course should last, adjusting it according to your blood sugar results. Your doctor will check your blood sugar regularly and may adjust the dose.

Amaryl-এর পার্শ্বপ্রতিক্রিয়া

Low blood sugar (hypoglycaemia) is the main concern with Amaryl 1 mg tablet and may be more likely in the first weeks of treatment, so careful monitoring is needed. If you experience symptoms of low blood sugar, take carbohydrates such as glucose or sugar immediately and contact your doctor. Low blood sugar can be quickly treated by taking glucose or sugar, but always follow your doctor's advice. Tell your doctor if any side effect bothers you or does not go away.

সতর্কতা ও নিরাপত্তা

It is not to be taken during pregnancy or while breastfeeding; insulin is needed instead. It is also not for people allergic to Glimepiride, other sulfonylureas or sulfonamides, or for those with severe liver or kidney problems or on dialysis. The risk of hypoglycaemia may be higher in the first weeks of treatment, so careful monitoring is needed. Tell your doctor about all other medicines you take, as many can interact with Glimepiride.

সাধারণ প্রশ্ন

What is Amaryl used for?

It is not suitable for type I diabetes, diabetic ketoacidosis or diabetic coma. Amaryl 1 mg tablet is used to lower blood glucose in adults with type II (non-insulin dependent) diabetes mellitus when diet and exercise alone are not enough.

How should I take Amaryl?

Follow your diet and exercise plan as advised. Amaryl is taken by mouth.

Can Amaryl cause side effects?

Low blood sugar (hypoglycaemia) is the main concern with Amaryl 1 mg tablet and may be more likely in the first weeks of treatment, so careful monitoring is needed. If you experience symptoms of low blood sugar, take carbohydrates such as glucose or sugar immediately and contact your doctor.

How much does Amaryl cost in Bangladesh?

The listed price is ৳ ৬.৯২.

Tablet
জেনেরিক নাম
Glimepiride
শক্তি
1 mg
ডোজ ফর্ম
Tablet
প্রস্তুতকারক
Synovia Pharma PLC.
বাংলাদেশে দাম

৳ ৬.৭৮ ৳ ৬.৯২ ২% ছাড় প্রতি ইউনিট

দাম হালনাগাদ: ১৮ Nov ২০২৬

আরও পাওয়া যায়

2 mg (Tablet)3 mg (Tablet)4 mg (Tablet)

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Glimepiride is indicated in following conditions-
  • Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
  • Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
  • ... Read more
Glimepiride is indicated in following conditions-
  • Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
  • Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
  • Glimepiride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.
  • Combined use of Glimepiride and insulin may increase the potential for hypoglycaemia.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. The primary mechanism of action of Glimepiride appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells. Glimepiride acts in concert with glucose by improving the sensitivity of beta cells to physiological glucose stimulus, resulting in insulin secretion. In addition, extrapancreatic effects like reduction of basal hepatic glucose production, increased peripheral tissue sensitivity to insulin and glucose uptake may also play role in the activity of Glimepiride. In non-fasting diabetic patients, the hypoglycaemic action of a single dose of Glimepiride persists for 24 hours.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

In principle, the dosage of Glimepiride is governed by the desired blood sugar level. The dosage of Glimepiride must be the lowest which is sufficient to achieve the desired metabolic control. The initial and the maintenance doses are set based on the results of regular check of glucose in blood and urine. Monitoring of glucose levels in blood and urine also serves to detect either primary or secondary failure of therapy.

Initial dose and dose titration: the usual initial dose is 1 mg once daily, if necessary, the daily dose can be increased. Any increase can be based on regular blood sugar monitoring, and should be gradual, i.e., at intervals of 1 to 2 weeks, and carried out stepwise, as follows: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.

Dose in patients with well controlled diabetes: the usual dose range in patients with well controlled diabetes is 1 to 4 mg daily.

Distribution of doses: Timing and distribution of doses are decided by the physician, in consideration of the patient's current life-style. Normally, a single daily dose is sufficient. This should be taken immediately before a substantial breakfast or if none is taken immediately before the first main meal. It is very important not to skip meals after taking the drug.

Secondary dosage adjustment: As control of diabetes improves, sensitivity to insuiin increases; therefore, Glimepiride requirement may fall as treatment proceeds. To avoid hypoglycaemia, timely dose reduction or cessation of Glimepiride therapy must be considered. A dose adjustment must also be considered whenever the patient's weight or life-styie changes, or other factors arise which cause an increased susceptibility to hypo or hyperglycaemia.

Changeover from other oral antidiabetics to Glimepiride: There is no exact dosage relationship between Glimepiride and other oral blood sugar lowering agents. When substituting Glimepiride for other such agents, the initial daily dose is 1 mg; this applies even in changeover from maximum dose of other oral blood sugar lowering agents. Any dose increase should be in accordance with guideline given above in 'initial dose and dose titration'. Consideration must be given to the potency and duration of action of the previous blood sugar lowering agent. It may be necessary to interrupt treatment to avoid additive effects which would increase the risk of hypoglycaemia.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Based on experience with Glimepiride and known interactions for other sulfonylureas, the following interactions must be considered.

In addition to insulin and other oral antidiabetic agents, drugs which may potentiate the hypoglycaemic action of Glimepiride include: ACE inhibitors, aminosalicylic acid, anabolic steroids and male sex hormones, azapropazone, chloramphenicol, ciofibrate, coumarin derivatives, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluconazole, fluoxetine, guanethidine, ifosfamide, MAO-inhibitors, miconazole, oxpentifylline (high dose parenteral), oxyphenbutazone, para-aminosalicylic acid, phenylbutazone, probenecid, quinolones, salicylates, sulphinpyrazone, sulfonamide antibiotics, tetracyclines, tritoqualine, trofosfamide.

Drugs which may attenuate the hypoglycaemic action of Glimepiride include:
  • Acetazoiamide, barbiturates, calcium channel blockers, corticosteroids, diazoxide, diuretics, glucagon, isoniazid, laxatives, nicotinic acid (high doses), oestrogens, phenothiazines, phenytoin, progestagens, rifampicin, sympathomimetic agents, thyroid hormones.
  • H2 receptor antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering effect.
  • Concomitant treatment with a beta-receptor blocker, clonidine, guanethidine or reserpine may mask the warning symptoms of a hypoglycaemic attack.
  • Acute and chronic aicohol intake may either potentiate or attenuate the activity of Glimepiride in an unpredictable fashion.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Glimepiride is not suitable for the treatment of insulin dependent (type I) diabetes mellitus, or for the treatment of diabetic ketoacidosis, nor for the treatment of diabetic coma. Glimepiride must not be used in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function and dialysis patients.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypoglycaemia, temporary visual impairment, nausea, vomiting, diarrhoea, abdominal pain, urticaria, fall in blood pressure.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Glimepiride must not be taken during pregnancy; a changeover to insulin is necessary. Patients planning a pregnancy must inform their physician, and should change over to insulin. Ingestion of Glimepiride with breast milk feeding may harm the child. Therefore, Glimepiride must not be taken by breastfeeding women. Either a changeover or complete discontinuation of breastfeeding is necessary.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

in the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring. If such risk present it may be necessary to adjust the dosage of Glimepiride, Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Overdosage of sulfonylureas, including Glimepiride, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurologic findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns. Close monitoring should continue until the physician is assured that the patient is out of danger. Severe hypoglycaemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medicai emergencies requiring immediate hospitalization. If hypoglycaemic coma is diagnosed or suspected, the patient should be given a rapid intravenous injection of  concentrated (50%) glucose solution. This should be followed by a continuous infusion of a more dilute (10%) glucose solution at a rate that will maintain the blood glucose at a level above 100 mg/dl. Patients should be closely monitored for a minimum of 24 to 48 hours, because hypoglycaemia may recur after apparent clinical recovery.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Do not store above 30°C. Keep away from light and out of the reach of children.

বিকল্প ব্র্যান্ড: Glimepiride

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Mepid Tablet

1 mg

Glimepiride

Renata PLC.

৳ ২.৪৬ ৳ ২.৫১ ২% ছাড় প্রতি ইউনিট

Adglim Tablet

1 mg

Glimepiride

UniMed UniHealth

৳ ২.৯৪ ৳ ৩.০০ ২% ছাড় প্রতি ইউনিট

Limerid Tablet

1 mg

Glimepiride

Supreme Pharmaceuticals Ltd.

৳ ২.৯৪ ৳ ৩.০০ ২% ছাড় প্রতি ইউনিট

Stimulin Tablet

1 mg

Glimepiride

Orion Pharma Ltd.

৳ ২.৯৫ ৳ ৩.০১ ২% ছাড় প্রতি ইউনিট

Mepid Tablet

2 mg

Glimepiride

Renata PLC.

৳ ৩.৯৩ ৳ ৪.০১ ২% ছাড় প্রতি ইউনিট

Adglim Tablet

2 mg

Glimepiride

UniMed UniHealth

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Dactus Tablet

1 mg

Glimepiride

The ACME Laboratories Ltd.

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Glucorid Tablet

1 mg

Glimepiride

Biopharma Ltd.

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Limerid Tablet

2 mg

Glimepiride

Supreme Pharmaceuticals Ltd.

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Stimulin Tablet

2 mg

Glimepiride

Orion Pharma Ltd.

৳ ৪.৯৩ ৳ ৫.০৩ ২% ছাড় প্রতি ইউনিট

Glimirid Tablet

1 mg

Glimepiride

Advanced Chemical Industries PLC

৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট

Glims Tablet

1 mg

Glimepiride

Opsonin Pharma Limited

৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট

সব দেখুন ৪১ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।